UPDATED Mar 12, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
0A8MAytu BioPharma | US$3.15 | 2.5% | n/a | US$17.5m | US$8.00 | PB0.5x | E96.6% | n/a | ||
0JDMIQVIA Holdings | US$258.32 | 0.9% | 36.4% | US$47.2b | US$272.88 | PE34.7x | E12.7% | 0% | ||
0LIFUltragenyx Pharmaceutical | US$48.02 | -5.4% | 20.1% | US$3.9b | US$90.53 | PS9x | E48.2% | n/a | ||
0QOKRoche Holding | CHF245.37 | 4.0% | -7.5% | CHF196.6b | CHF282.00 | PE17x | E8.3% | 3.9% | ||
0QZUVertex Pharmaceuticals | US$415.28 | 0.7% | 41.1% | US$106.5b | US$463.13 | PE29.4x | E11.2% | n/a | ||
0QQ6Roche Holding | CHF258.60 | 2.9% | -8.1% | CHF196.6b | CHF297.19 | PE17x | E8.3% | 3.9% | ||
BXPBeximco Pharmaceuticals | ৳0.40 | -1.2% | -5.9% | ৳54.0b | n/a | PE11x | E15.0% | 2.9% | ||
0R0TAmgen | US$275.75 | -0.9% | 18.9% | US$148.2b | US$302.78 | PE22.1x | E9.2% | 3.3% | ||
0P6SBayer | €26.49 | 2.6% | -52.5% | €26.0b | €39.10 | PB0.8x | E43.2% | 0.4% | ||
ROZRoche Holding | CHF258.80 | 3.9% | -8.2% | CHF196.6b | CHF297.42 | PE17x | E8.3% | 3.9% | ||
0ABRH. Lundbeck | kr.28.94 | -1.4% | 9.0% | kr.31.8b | kr.34.78 | PE14x | E9.6% | 2.2% | ||
0R2MRegeneron Pharmaceuticals | US$973.05 | 0.2% | 27.5% | US$104.3b | US$1,019.82 | PE26.4x | E9.5% | n/a | ||
0QYQGilead Sciences | US$74.99 | 3.2% | -5.7% | US$93.5b | US$87.53 | PE16.5x | E6.5% | 4.1% | ||
0DTFBoiron | €34.98 | -1.5% | -14.3% | €607.3m | €40.46 | PE12.8x | E5.9% | 3.1% | ||
0IMTPhotocure | kr54.00 | -6.1% | -15.2% | kr1.5b | kr85.67 | PE5502.4x | E88.3% | 0% | ||
0A3SNovavax | US$5.07 | -8.8% | -16.5% | US$708.2m | US$15.43 | PE-1.3x | E73.3% | n/a | ||
0W4NFormycon | €48.20 | 0.4% | -30.4% | €773.1m | €103.33 | PS11.3x | E72.1% | n/a | ||
0A2VSanofi | €48.42 | 1.6% | 1.9% | €110.3b | €58.66 | PE20.4x | E13.9% | 4.3% | ||
ROGZRoche Holding | CHF245.30 | 4.5% | -7.7% | CHF196.6b | CHF281.91 | PE17x | E8.3% | 3.9% | ||
0DPBBavarian Nordic | kr.169.37 | 7.9% | -7.7% | kr.13.1b | kr.282.41 | PE8.8x | E-24.6% | n/a | ||
0JAVInsmed | US$27.14 | -2.8% | 48.3% | US$4.1b | US$43.13 | PS13.3x | E39.6% | n/a | ||
EAHECO Animal Health Group | UK£0.92 | -1.1% | -14.4% | UK£62.3m | UK£2.00 | PB0.8x | E46.4% | 0% | ||
0VGITG Therapeutics | US$16.05 | -11.7% | 10.1% | US$2.3b | US$30.14 | PE181x | E49.9% | n/a | ||
0IRFEvotec | €13.25 | 1.3% | -22.4% | €2.3b | €23.23 | PS2.9x | E50.7% | n/a |